333489
Evaluating the Impact of City-wide Collaborations in the Reduction of Racial Disparities in Breast Cancer Mortality
Methods:Vital records data was utilized to calculate 3-year interval age-adjusted breast cancer mortality rates for non-Hispanic Black and non-Hispanic White women in Chicago, New York, Los Angeles, Houston, Philadelphia and the United States from 1999 – 2010. The disparity in breast cancer mortality was measured based on race specific rate ratios. SAS 9.2 was used for data analysis.
Results: Findings reveal a 35% reduction in the disparity in Chicago starting in the 2008 - 2010 interval compared to 2005-2007. In the later interval, Chicago and the US have contrasting trends despite consistent levels of the disparity, 40%.The disparity trend increases across the study period for the US, Los Angeles, Houston and Philadelphia. Despite increasing trends, breast cancer mortality rates are declining for both black and white women in all locales except Chicago. In the later interval, Chicago mortality rates for black women decreased compared to a slight increase for white women.
Conclusion:For the first time improvements in breast cancer survival has been demonstrated for black women in Chicago. Increasing disparities in metropolitan areas comparable to Chicago suggests that this is not a secular trend. Preliminary data indicates collaborative efforts in Chicago have contributed to these findings. Further analysis is needed to understand the race-specific trends in breast cancer survival.
Learning Areas:
EpidemiologyLearning Objectives:
Describe trend in racial disparities in breast cancer disparities from 2000-2010 for the US and the 5 largest metropolitan areas
Describe the trend in race-specific breast cancer mortality rates from 2000-2010 for the US and the 5 largest metropolitan areas
Keyword(s): Cancer, Epidemiology
Qualified on the content I am responsible for because: I have a background in breast cancer research that spans the past four years. I am currently an evaluation consultant working with the Breast Cancer Task Force conducting disparities research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.